Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
HLVX
Shares outstanding
50,204,082 shares
Disclosed Ownership
4,920,000 shares
Ownership
9.8%
Form type
SCHEDULE 13D
Filing time
02 May 2025, 16:15:10 UTC
Date of event
02 May 2025
Next filing
19 Sep 2025

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 9.8% ownership in HilleVax, Inc. Common Stock, par value $0.0001 per share (HLVX) on 02 May 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D for HilleVax, Inc. Common Stock, par value $0.0001 per share (HLVX).
  • Disclosed ownership: 9.8%.
  • Date of event: 02 May 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 02 May 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 9.8% 4,920,000 0 4,920,000 /s/ Kevin Tang Manager 0001232621
KEVIN TANG 9.8% 4,920,000 0 4,920,000 /s/ Kevin Tang Self 0001178579
TANG CAPITAL PARTNERS, LP 5.5% 2,767,008 0 2,767,008 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0001191935
TANG CAPITAL PARTNERS INTERNATIONAL, LP 4.3% 2,152,992 0 2,152,992 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner 0002064011
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
CONCENTRA BIOSCIENCES, LLC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer 0001970065